Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

69.53

+0.31 (0.45%)

At close: Feb 27, 2026, 4:00 PM EST

69.64

+0.11 (0.16%)

After-hours: Feb 27, 2026, 7:21 PM EST

Halozyme Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	8,206	7,914	6,083	4,882	7,694	5,659
Market Cap Growth	10.99%	30.11%	24.59%	-36.54%	35.96%	-1.84%
Enterprise Value	10,240	8,751	6,951	5,929	8,940	5,722
Last Close Price	69.53	67.30	47.81	36.96	56.90	40.21
PE Ratio	27.16	24.98	13.70	17.34	38.06	14.05
Forward PE	8.67	8.85	10.38	9.77	21.92	17.89
PS Ratio	5.88	5.67	5.99	5.89	11.66	12.76
PB Ratio	167.77	162.13	16.72	58.26	45.31	28.73
P/TBV Ratio	-	-	-	-	-	28.73
P/FCF Ratio	12.73	12.28	12.99	13.08	32.70	18.99
P/OCF Ratio	12.59	12.15	12.70	12.57	32.04	18.90
PEG Ratio	-	0.41	0.41	0.41	0.41	0.46
EV/Sales Ratio	7.33	6.27	6.85	7.15	13.54	12.91
EV/EBITDA Ratio	11.41	9.75	11.09	14.22	26.60	20.63
EV/EBIT Ratio	12.54	10.72	12.61	17.56	30.89	20.74
EV/FCF Ratio	15.89	13.58	14.84	15.88	37.99	19.20
Debt / Equity Ratio	44.60	44.60	4.14	18.27	9.07	4.47
Debt / EBITDA Ratio	2.40	2.40	2.38	3.59	4.54	3.15
Debt / FCF Ratio	3.38	3.38	3.22	4.10	6.55	2.95
Net Debt / Equity Ratio	41.68	41.68	2.50	14.26	6.94	0.70
Net Debt / EBITDA Ratio	2.27	2.27	1.45	2.87	3.51	0.50
Net Debt / FCF Ratio	3.16	3.16	1.94	3.20	5.01	0.47
Asset Turnover	0.61	0.61	0.54	0.46	0.45	0.53
Inventory Turnover	1.95	1.95	1.77	2.36	2.67	2.04
Quick Ratio	3.30	3.30	6.50	5.07	4.54	7.10
Current Ratio	4.66	4.66	7.80	6.64	5.65	7.91
Return on Equity (ROE)	153.59%	153.59%	198.42%	222.07%	110.23%	231.44%
Return on Assets (ROA)	22.24%	22.24%	18.16%	11.80%	12.28%	20.47%
Return on Invested Capital (ROIC)	32.36%	33.01%	34.44%	20.77%	27.92%	105.98%
Return on Capital Employed (ROCE)	34.80%	34.80%	28.70%	20.80%	16.90%	27.90%
Earnings Yield	3.86%	4.00%	7.30%	5.77%	2.63%	7.12%
FCF Yield	7.86%	8.14%	7.70%	7.65%	3.06%	5.27%
Buyback Yield / Dilution	4.26%	4.26%	3.56%	4.56%	4.21%	-3.77%

Updated Feb 17, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q